Recto, Rudita .
HRN: 14-79-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2023
MUPIROCIN 2%, 15G (TUBE)
08/04/2023
08/11/2023
TOPICAL
Sufficient Amount
BID
Decubitus Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes